Mary Chapman, features writer —

Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.

Articles by Mary Chapman

‘Sickle Cell Matters’ during Sickle Cell Awareness Month

The sickle cell disease (SCD) community will mark National Sickle Cell Awareness Month through September to help bring greater visibility to the inherited blood disorder and the roughly 100,000 U.S. residents affected by it. The campaign also seeks to raise funds for research and support those with SCD and…

Colorado House passes sickle cell disease outreach legislation

The Colorado House of Representatives has passed legislation that seeks to improve health outcomes for state residents who live with sickle cell disease (SCD) through a new community outreach program. If made into law, the measure (SB24-042) would appropriate $200,000 to establish the Arie P. Taylor Sickle Cell…

RoslinCT to manufacture CRISPR-based gene therapy Casgevy

RoslinCT will manufacture the groundbreaking new gene therapy Casgevy (exagamglogene autotemcel) for sickle cell disease (SCD) patients in the U.S. and U.K. RoslinCT, a cell and gene therapy contract development and manufacturing company, has facilities in Edinburgh, Scotland and Hopkinton, Massachusetts. The company worked with Vertex…